ARCHIVES

Animas As Early Warning “Sentinels” Part Of DCE Study

This article is from The Cancer Letter archive.

Vol. 13 No. 31 | July 31, 1987

Download PDF Visit The Full Archive

Related Articles

Faulding, NaPro In Agreement For Marketing Paclitaxel.

March 30, 2001

Cancer Meetings Listed

November 1, 1996

RTOG: Hormone Therapy Increases Survival When Combined With Radiation Therapy

July 29, 2011

NCI contract Award

August 1, 1997

Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer

April 24, 2009

Politics, Short Tempers, Grievances Dominate NIH Panel On Unconventional Medical Practices

September 25, 1992